In-Vivo Efficacy of Chloroquine to Clear Asymptomatic Infections in Mozambican Adults: A Randomized, Placebo-controlled Trial with Implications for Elimination Strategies

Abstract Recent reports regarding the re-emergence of parasite sensitivity to chloroquine call for a new consideration of this drug as an interesting complementary tool in malaria elimination efforts, given its good safety profile and long half-life. A randomized (2:1), single-blind, placebo-control...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Beatriz Galatas, Lidia Nhamussua, Baltazar Candrinho, Lurdes Mabote, Pau Cisteró, Himanshu Gupta, Regina Rabinovich, Clara Menéndez, Eusebio Macete, Francisco Saute, Alfredo Mayor, Pedro Alonso, Quique Bassat, Pedro Aide
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/6bfb991774b04f97b3e7944417ea6562
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6bfb991774b04f97b3e7944417ea6562
record_format dspace
spelling oai:doaj.org-article:6bfb991774b04f97b3e7944417ea65622021-12-02T16:06:25ZIn-Vivo Efficacy of Chloroquine to Clear Asymptomatic Infections in Mozambican Adults: A Randomized, Placebo-controlled Trial with Implications for Elimination Strategies10.1038/s41598-017-01365-42045-2322https://doaj.org/article/6bfb991774b04f97b3e7944417ea65622017-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-01365-4https://doaj.org/toc/2045-2322Abstract Recent reports regarding the re-emergence of parasite sensitivity to chloroquine call for a new consideration of this drug as an interesting complementary tool in malaria elimination efforts, given its good safety profile and long half-life. A randomized (2:1), single-blind, placebo-controlled trial was conducted in Manhiça, Mozambique, to assess the in-vivo efficacy of chloroquine to clear plasmodium falciparum (Pf) asymptomatic infections. Primary study endpoint was the rate of adequate and parasitological response (ACPR) to therapy on day 28 (PCR-corrected). Day 0 isolates were analyzed to assess the presence of the PfCRT-76T CQ resistance marker. A total of 52 and 27 male adults were included in the CQ and Placebo group respectively. PCR-corrected ACPR was significantly higher in the CQ arm 89.4% (95%CI 80–98%) compared to the placebo (p < 0.001). CQ cleared 49/50 infections within the first 72 h while placebo cleared 12/26 (LRT p < 0.001). The PfCRT-76T mutation was present only in one out of 108 (0.9%) samples at baseline, well below the 84% prevalence found in 1999 in the same area. This study presents preliminary evidence of a return of chloroquine sensitivity in Mozambican Pf isolates, and calls for its further evaluation in community-based malaria elimination efforts, in combination with other effective anti-malarials. Trial registration: www.clinicalTrials.gov NCT02698748.Beatriz GalatasLidia NhamussuaBaltazar CandrinhoLurdes MabotePau CisteróHimanshu GuptaRegina RabinovichClara MenéndezEusebio MaceteFrancisco SauteAlfredo MayorPedro AlonsoQuique BassatPedro AideNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-10 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Beatriz Galatas
Lidia Nhamussua
Baltazar Candrinho
Lurdes Mabote
Pau Cisteró
Himanshu Gupta
Regina Rabinovich
Clara Menéndez
Eusebio Macete
Francisco Saute
Alfredo Mayor
Pedro Alonso
Quique Bassat
Pedro Aide
In-Vivo Efficacy of Chloroquine to Clear Asymptomatic Infections in Mozambican Adults: A Randomized, Placebo-controlled Trial with Implications for Elimination Strategies
description Abstract Recent reports regarding the re-emergence of parasite sensitivity to chloroquine call for a new consideration of this drug as an interesting complementary tool in malaria elimination efforts, given its good safety profile and long half-life. A randomized (2:1), single-blind, placebo-controlled trial was conducted in Manhiça, Mozambique, to assess the in-vivo efficacy of chloroquine to clear plasmodium falciparum (Pf) asymptomatic infections. Primary study endpoint was the rate of adequate and parasitological response (ACPR) to therapy on day 28 (PCR-corrected). Day 0 isolates were analyzed to assess the presence of the PfCRT-76T CQ resistance marker. A total of 52 and 27 male adults were included in the CQ and Placebo group respectively. PCR-corrected ACPR was significantly higher in the CQ arm 89.4% (95%CI 80–98%) compared to the placebo (p < 0.001). CQ cleared 49/50 infections within the first 72 h while placebo cleared 12/26 (LRT p < 0.001). The PfCRT-76T mutation was present only in one out of 108 (0.9%) samples at baseline, well below the 84% prevalence found in 1999 in the same area. This study presents preliminary evidence of a return of chloroquine sensitivity in Mozambican Pf isolates, and calls for its further evaluation in community-based malaria elimination efforts, in combination with other effective anti-malarials. Trial registration: www.clinicalTrials.gov NCT02698748.
format article
author Beatriz Galatas
Lidia Nhamussua
Baltazar Candrinho
Lurdes Mabote
Pau Cisteró
Himanshu Gupta
Regina Rabinovich
Clara Menéndez
Eusebio Macete
Francisco Saute
Alfredo Mayor
Pedro Alonso
Quique Bassat
Pedro Aide
author_facet Beatriz Galatas
Lidia Nhamussua
Baltazar Candrinho
Lurdes Mabote
Pau Cisteró
Himanshu Gupta
Regina Rabinovich
Clara Menéndez
Eusebio Macete
Francisco Saute
Alfredo Mayor
Pedro Alonso
Quique Bassat
Pedro Aide
author_sort Beatriz Galatas
title In-Vivo Efficacy of Chloroquine to Clear Asymptomatic Infections in Mozambican Adults: A Randomized, Placebo-controlled Trial with Implications for Elimination Strategies
title_short In-Vivo Efficacy of Chloroquine to Clear Asymptomatic Infections in Mozambican Adults: A Randomized, Placebo-controlled Trial with Implications for Elimination Strategies
title_full In-Vivo Efficacy of Chloroquine to Clear Asymptomatic Infections in Mozambican Adults: A Randomized, Placebo-controlled Trial with Implications for Elimination Strategies
title_fullStr In-Vivo Efficacy of Chloroquine to Clear Asymptomatic Infections in Mozambican Adults: A Randomized, Placebo-controlled Trial with Implications for Elimination Strategies
title_full_unstemmed In-Vivo Efficacy of Chloroquine to Clear Asymptomatic Infections in Mozambican Adults: A Randomized, Placebo-controlled Trial with Implications for Elimination Strategies
title_sort in-vivo efficacy of chloroquine to clear asymptomatic infections in mozambican adults: a randomized, placebo-controlled trial with implications for elimination strategies
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/6bfb991774b04f97b3e7944417ea6562
work_keys_str_mv AT beatrizgalatas invivoefficacyofchloroquinetoclearasymptomaticinfectionsinmozambicanadultsarandomizedplacebocontrolledtrialwithimplicationsforeliminationstrategies
AT lidianhamussua invivoefficacyofchloroquinetoclearasymptomaticinfectionsinmozambicanadultsarandomizedplacebocontrolledtrialwithimplicationsforeliminationstrategies
AT baltazarcandrinho invivoefficacyofchloroquinetoclearasymptomaticinfectionsinmozambicanadultsarandomizedplacebocontrolledtrialwithimplicationsforeliminationstrategies
AT lurdesmabote invivoefficacyofchloroquinetoclearasymptomaticinfectionsinmozambicanadultsarandomizedplacebocontrolledtrialwithimplicationsforeliminationstrategies
AT paucistero invivoefficacyofchloroquinetoclearasymptomaticinfectionsinmozambicanadultsarandomizedplacebocontrolledtrialwithimplicationsforeliminationstrategies
AT himanshugupta invivoefficacyofchloroquinetoclearasymptomaticinfectionsinmozambicanadultsarandomizedplacebocontrolledtrialwithimplicationsforeliminationstrategies
AT reginarabinovich invivoefficacyofchloroquinetoclearasymptomaticinfectionsinmozambicanadultsarandomizedplacebocontrolledtrialwithimplicationsforeliminationstrategies
AT claramenendez invivoefficacyofchloroquinetoclearasymptomaticinfectionsinmozambicanadultsarandomizedplacebocontrolledtrialwithimplicationsforeliminationstrategies
AT eusebiomacete invivoefficacyofchloroquinetoclearasymptomaticinfectionsinmozambicanadultsarandomizedplacebocontrolledtrialwithimplicationsforeliminationstrategies
AT franciscosaute invivoefficacyofchloroquinetoclearasymptomaticinfectionsinmozambicanadultsarandomizedplacebocontrolledtrialwithimplicationsforeliminationstrategies
AT alfredomayor invivoefficacyofchloroquinetoclearasymptomaticinfectionsinmozambicanadultsarandomizedplacebocontrolledtrialwithimplicationsforeliminationstrategies
AT pedroalonso invivoefficacyofchloroquinetoclearasymptomaticinfectionsinmozambicanadultsarandomizedplacebocontrolledtrialwithimplicationsforeliminationstrategies
AT quiquebassat invivoefficacyofchloroquinetoclearasymptomaticinfectionsinmozambicanadultsarandomizedplacebocontrolledtrialwithimplicationsforeliminationstrategies
AT pedroaide invivoefficacyofchloroquinetoclearasymptomaticinfectionsinmozambicanadultsarandomizedplacebocontrolledtrialwithimplicationsforeliminationstrategies
_version_ 1718385030460342272